
Esozole 40mg Injection
Marketer
Kabir Life Sciences
Salt Composition
Esomeprazole (40mg)
Overview Esozole 40mg Injection
Acid-reducing injection, Esozole 40mg, lowers stomach acid production. It treats acid-related stomach and intestinal disorders like reflux and other conditions stemming from excessive acid. This intravenous medication also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. A proton pump inhibitor (PPI), Esozole 40mg is intravenously administered by a healthcare provider only when deemed superior to oral forms by your physician. Dosage and treatment duration are determined by your condition and response. Lifestyle modifications, such as smaller, more frequent meals and avoidance of caffeine, spices, and fatty foods, can enhance treatment effectiveness. Common, usually mild, side effects include injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome side effects warrant medical attention. Discuss bone loss (osteoporosis) prevention, including calcium and vitamin D supplementation, with your doctor. Esozole 40mg is contraindicated in individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or lactating individuals require medical consultation. Alcohol should be avoided due to its acid-stimulating effects.
Uses of Esozole 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Esozole 40mg Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Esozole 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esozole 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Esozole 40mg Injection works:
Acid reflux and heartburn can be alleviated with a single 40mg injection of the proton pump inhibitor (PPI), Esozole. This medication diminishes stomach acid production, thus providing relief from acid-related discomfort.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Esozole 40mg Injection concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Esozole 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of 40mg Esozole Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esozole 40mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with severely impaired kidney function, administration of a 40mg Esozole Injection necessitates careful monitoring. A modified dosage of Esozole 40mg Injection may be necessary. Physician consultation is advised. Dosage alteration is unnecessary for patients exhibiting mild to moderate kidney impairment.
LiverCAUTION
For individuals with significant hepatic impairment, the administration of a 40mg Esozole injection requires careful monitoring. Dosage modification of the 40mg Esozole injection may be necessary. Physician consultation is advised. No dosage alteration is needed for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Esozole 40mg Injection :
Omitting a scheduled dose of the 40mg Esozole injection necessitates contacting your physician.
Facts to Know About Esozole 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
